Comparison between levofluxain and clarithromycin treatment in helicobacter pylori eradication

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015030421328N1

Enrollment

Registered

2015-03-26

Start date

2014-10-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori. Diseases of oesophagus, stomach and duodenum

Interventions

Intervention 1: First group: Omeprazole 20 mg daily, Clarithromycin 500 mg daily Ampxicillin 1 gr BD. Intervention 2: Second group: Omeprazole 20 mg daily, levofluxacin 500 mg daily Ampxicillin 1 gr B

Treatment - Drugs

First group: Omeprazole 20 mg daily, Clarithromycin 500 mg daily Ampxicillin 1 gr BD

Second group: Omeprazole 20 mg daily, levofluxacin 500 mg daily Ampxicillin 1 gr BD

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:complaint of dyspepsia Exclusion criteria:using ppi or h2b during recent 4weeks,past history of gastric surgery,past history of gastric cancer,pregnancy,comorbid diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Eradication rate of helicobacter pylori. Timepoint: 4 weeks after the end of the intervention. Method of measurement: Stool Ag.	—

Secondary

Measure	Time frame
Eradication rate of HP in male and female. Timepoint: 4 weeks after intervention. Method of measurement: Stool Ag.;Endoscopic findings. Timepoint: Before the intervention. Method of measurement: Endoscopic.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Narges sadeghi

Babol University Of Medical Sciences

internalmedbabol@gmail.com+98 11 3223 8284

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026